Oneness Biotech Co., Ltd. (LUX:ONEA)
11.30
+0.30 (2.73%)
At close: Dec 4, 2025
Oneness Biotech Revenue
Oneness Biotech had revenue of 34.05M TWD in the quarter ending September 30, 2025, with 16.23% growth. This brings the company's revenue in the last twelve months to 117.33M, up 4.57% year-over-year. In the year 2024, Oneness Biotech had annual revenue of 117.93M with 35.89% growth.
Revenue (ttm)
117.33M TWD
Revenue Growth
+4.57%
P/S Ratio
282.41
Revenue / Employee
2.73M TWD
Employees
43
Market Cap
926.39M EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
| Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
| Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
| Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
| Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reinet Investments S.C.A. | 137.00M |
| CPI FIM | 177.69M |
| Luxempart | 97.19M |
| Socfinasia | 199.82M |
| Socfinaf | 663.01M |
| Fotex Holding S.E. | 42.87M |
| Velcan Holdings | 2.99M |